Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Legend Biotech (LEGN) EPS (Basic) (2019 - 2025)

Legend Biotech (LEGN) posted EPS (Basic) of $0.0 for Q4 2025, up 100.0% on a QoQ basis from -$53412.5 in Q3 2025, and down 100.0% year-over-year from $0.59 in Q4 2024.

Legend Biotech (LEGN) has 7 years of EPS (Basic) data on file, last reported at $0.0 in Q4 2025.

  • In Q4 2025, EPS (Basic) fell 100.0% year-over-year to $0.0; the TTM figure through Dec 2025 stood at -$253763.6 (up 78.35% YoY), while the FY2025 annual figure was $0.0, up 100.07% from the prior year.
  • EPS (Basic) improved to $0.0 in Q4 2025, from -$53412.5 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.59 in Q4 2024 and bottomed at -$948228.6 in Q2 2024.
  • A 5-year average of -$79211.4 and a median of -$3.17 in 2021 frame the typical range for EPS (Basic).
  • The widest YoY moves for EPS (Basic): up 114.67% in 2024, down 17142757.14% in 2024.
  • Year by year, EPS (Basic) stood at -$0.31 in 2021, then tumbled by 36.23% to -$0.43 in 2022, then plunged by 841.71% to -$4.02 in 2023, then soared by 114.67% to $0.59 in 2024, then slumped by 100.0% to $0.0 in 2025.
  • The last three EPS (Basic) figures came in at $0.0 (Q4 2025), -$53412.5 (Q3 2025), and -$200348.4 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 4.06
7 Evaxion A 62.56 Bn 62.54 Bn - 0.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 6.99
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.55
10 Revolution Medicines 32.39 Bn 32.39 Bn - -2.29

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 -1.04
Jun 30, 2025 -200,348.39
Mar 31, 2025 -2.73
Dec 31, 2024 0.59
Sep 30, 2024 -3.39
Jun 30, 2024 -948,228.57
Mar 31, 2024 -2.99
Dec 31, 2023 -4.02
Sep 30, 2023 -1.73
Jun 30, 2023 -5.53
Mar 31, 2023 -3.40
Dec 31, 2022 -0.43
Mar 31, 2022 -1.04
Dec 31, 2021 -0.31
Sep 30, 2021 -0.43
Jun 30, 2021 -0.33
Mar 31, 2021 -3.35
Dec 31, 2020 -0.24
Sep 30, 2020 -2,559.46
Jun 30, 2020 -0.63
Mar 31, 2020 -0.22
Dec 31, 2019 -0.32
Sep 30, 2019 -0.14
Jun 30, 2019 -0.14